Skip to main content

Is keytruda.com a Scam? Security Check Results - Merck

keytruda.com Security Report Summary

keytruda.com received a security score of 68 out of 100 in Guard's comprehensive security analysis, classified as "Moderate Risk". This report covers Merck's website security posture. Merck operates in the Healthcare industry in United States.

The website www.keytruda.com serves as the official patient-facing platform for KEYTRUDA®, an immunotherapy drug developed by Merck & Co., Inc. It provides comprehensive information about the drug's indications, safety information, side effects, and patient resources. The site targets patients in the United States and its territories, offering educational content and support to help patients understand treatment options. The site is well-branded and professionally designed, reflecting Merck's position as a leading pharmaceutical company in oncology treatments. Technically, the site leverages modern web technologies including React and Next.js, with embedded video content via Brightcove and analytics through Google Tag Manager. The site is mobile-optimized and accessible, with good SEO practices implemented. Security posture is strong with HTTPS enforced and appropriate security headers present, though explicit security and incident response policies are not publicly detailed. WHOIS data is unavailable, likely due to privacy protection, but the site's content and branding strongly support its legitimacy. Overall, the site presents a trustworthy, professional resource for patients seeking information about KEYTRUDA treatment.

The security scan identified 27 findings across security headers, SSL/TLS, DNS health, email security, GDPR compliance, and NIS2 compliance analysis modules.

Technologies detected: React, Next.js, Brightcove Video Player, Google Tag Manager, jQuery.

About this security scan

Guard performs automated security assessments of websites by analyzing SSL/TLS certificates, HTTP security headers, DNS configuration, email authentication protocols (SPF, DKIM, DMARC), GDPR compliance indicators, NIS2 directive compliance, network exposure, and AI-powered business intelligence. Each report provides domain-specific findings, risk scores, and actionable recommendations.

keytruda.com favicon

Is keytruda.com Safe? Security Analysis for Merck

https://keytruda.com

Check if keytruda.com is a scam or legitimate. Free security scan and reviews.

HealthcareUnited Statesenterprise
ReactNext.jsBrightcove Video PlayerGoogle Tag ManagerjQuery
Analyzed 7/29/2025Completed 3:25:00 AM8mo ago
68
Security Score
MEDIUM RISK

Above Healthcare avg (65)

10,000+

Domains scanned

500+

Security teams trust us

EveryPay

Secure checkout

Instant

Reports delivered

Professional PDF & Marketing Data

Get the professional PDF report for keytruda.com

Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.

PDF Report & Export

PDF download, email delivery, unlock code

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

Plan Comparison

FeaturePDF ReportMarketing+
Full security analysis
Professional PDF export
Email delivery
Lifetime access + unlock code
Contact emails & phones
Marketing outreach data

Already purchased?

Order summary

Domainkeytruda.com
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

AI Summary

The website www.keytruda.com serves as the official patient-facing platform for KEYTRUDA®, an immunotherapy drug developed by Merck & Co., Inc. It provides comprehensive information about the drug's indications, safety information, side effects, and patient resources. The site targets patients in the United States and its territories, offering educational content and support to help patients understand treatment options. The site is well-branded and professionally designed, reflecting Merck's position as a leading pharmaceutical company in oncology treatments. Technically, the site leverages modern web technologies including React and Next.js, with embedded video content via Brightcove and analytics through Google Tag Manager. The site is mobile-optimized and accessible, with good SEO practices implemented. Security posture is strong with HTTPS enforced and appropriate security headers present, though explicit security and incident response policies are not publicly detailed. WHOIS data is unavailable, likely due to privacy protection, but the site's content and branding strongly support its legitimacy. Overall, the site presents a trustworthy, professional resource for patients seeking information about KEYTRUDA treatment.

Detected Technologies

ReactNext.jsBrightcove Video PlayerGoogle Tag ManagerjQuery

7 urgent findings need attention

7 high

Continuous monitoring

Keep keytruda.com under constant watch

Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.

Security drift alerts

Risk score drops, new high-severity issues, and header hardening gaps

Compliance watch

GDPR / NIS2 posture changes with governance evidence snapshots

Infrastructure surface

Unexpected open services, SSL expiry, DNS & email authentication changes

Content & tracker intelligence

Marketing tech shifts, analytics drift, and AI recommendation updates

25 €
per month · billed securely via EveryPay
Less than 1 € / day — cheaper than a single incident response hour

Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.

Purchase to access the monitoring timeline, JSON diffs, alert history, and PDF export for keytruda.com.

Security Headers

6 findings

45/100

GDPR Compliance

3 findings

68/100

NIS2 Compliance

8 findings

17/100

Email Security

5 findings

50/100

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Business Intelligence

Market & Strategic Analysis

KEYTRUDA.com is positioned as a critical digital asset for Merck's oncology portfolio, focusing on patient education and support. The business model centers on pharmaceutical marketing and patient engagement, providing detailed drug information, safety guidelines, and financial support resources. The site supports Merck's competitive advantage in immunotherapy by educating patients and caregivers, potentially improving treatment adherence and outcomes. The presence of a dedicated healthcare professional site indicates a segmented approach to stakeholder engagement. The site integrates with Merck's broader digital ecosystem, linking to corporate and regulatory resources. Growth indicators include comprehensive content updates and multimedia integration. The partnership ecosystem includes regulatory bodies like the FDA and technology providers such as Brightcove and Google. Strategic observations highlight the importance of digital patient support in pharmaceutical marketing and compliance with healthcare regulations.

Security Posture Analysis

Comprehensive Security Assessment

The website demonstrates a mature security posture with HTTPS enforced and multiple security headers implemented, including HSTS, CSP, and X-Frame-Options. No exposed sensitive data or vulnerable libraries were detected in the analysis. The site lacks a publicly visible dedicated security policy or incident response contact, which could be improved to enhance transparency and trust. No vulnerability disclosure or security.txt file was found, representing an opportunity for better security communication. Privacy compliance is strong, with clear privacy and cookie policies and consent mechanisms in place, aligning with GDPR requirements. Overall, the site balances user experience with security best practices, though formal security governance disclosures are limited.

Strategic Recommendations

Priority Actions for Security Improvement

1

Publish a dedicated security policy page outlining security practices and compliance.

Observations

AI-powered comprehensive website and business analysis.

AI-Enhanced Website Analysis

Business Insights

Company:

Merck

Description:

KEYTRUDA is an immunotherapy that works with your immune system to help fight certain cancers. It treats 18 types of cancer including early-stage and advanced cancers such as non–small cell lung cancer (NSCLC).

Key Services:
Cancer treatment informationPatient resources and supportMedication guides and prescribing information
Content Quality:

excellent

Branding:

consistent

Technical Stack

Technologies:
ReactNext.jsBrightcove Video PlayerGoogle Tag ManagerjQuery
Frameworks:
Next.js
Performance:

moderate

Mobile:

good

Accessibility:

good

SEO:

good

Security Assessment

Security Score:
90/100
Best Practices:
  • HTTPS enforced
  • Security headers present
  • No exposed sensitive data detected
  • Secure forms with no visible vulnerabilities

Analytics & Tracking

Services:
Google Analytics (via Google Tag Manager)
Tracking Level:moderate
Privacy Compliance:good

Advertising & Marketing

Transparency Level:good

Website Quality Assessment

Design Quality:excellent
User Experience:excellent
Content Relevance:excellent
Navigation Clarity:excellent
Professionalism:excellent
Trustworthiness:high

Key Observations

1

Website is fully accessible with no blocking or WAF challenges.

Get this report delivered to your inbox

Receive a summary of the keytruda.com security findings by email. Quick and easy to share with decision makers.

🛡️Security Headers

HTTP security headers analysis and recommendations.

Security Headers

HTTP security headers analysis

45/100
Score

Missing Strict-Transport-Security header

HIGH

Forces HTTPS connections

Missing X-Content-Type-Options header

MEDIUM

Prevents MIME type sniffing

Missing X-XSS-Protection header

MEDIUM

Legacy XSS protection (deprecated but still recommended)

Missing Referrer-Policy header

LOW

Controls referrer information sent with requests

Missing Permissions-Policy header

MEDIUM

Controls browser features and APIs

Sensitive data may be cached

LOW

Cache-Control header should include "no-store" for sensitive pages

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

GDPR Compliance

Privacy and data protection assessment

68/100
Score

No Cookie Consent Banner found

HIGH

GDPR requires explicit consent for non-essential cookies

No Data Protection Officer mentioned

LOW

Large organizations may need to designate a DPO under GDPR

Privacy policy may not be GDPR compliant

MEDIUM

Privacy policy lacks explicit GDPR compliance elements

GDPR Compliance Analysis

Privacy Policy85% confidence
Cookie Policy85% confidence
Contact Information Found90% confidence
phone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

NIS2 Compliance

Network & Information Security Directive

17/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity

No security contact information

HIGH

NIS2 requires clear incident reporting channels

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts

Need this report as a PDF?

Download the complete keytruda.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Email Security

SPF, DKIM, and DMARC validation

50/100
Score

No SPF record found

HIGH

SPF helps prevent email spoofing

No DKIM record found

MEDIUM

DKIM adds cryptographic signatures to emails

No BIMI Record

LOW

BIMI displays brand logos in email clients

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
DMARC Details
Policy:reject
Aggregate Reports:merck@rua.agari.com
Forensic Reports:merck@ruf.agari.com

🏆SSL/TLS Security

Certificate validity and encryption analysis.

SSL/TLS Security

Certificate validity and encryption analysis

90/100
Score

Mixed Content Detected

MEDIUM

4 resources loaded over insecure HTTP

Partial SSL/TLS Assessment

LOW

Completed 2 of 4 security checks due to time constraints

Certificate Details

Subject:keytruda.com
Issuer:Amazon RSA 2048 M02
Valid Until:12/6/2025 (130 days)
SANs:keytruda.com, www.keytruda.com

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

DNS Health

DNS configuration and security assessment

85/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found

Domain Registration Details

Domain Age
13 years(mature)
Expiry Risk
none(226 days)
Protection Level
strongDNSSEC OFF

DNS Records

A Records:166.117.141.238, 166.117.40.138
Name Servers:
ns-1529.awsdns-63.org
ns-1633.awsdns-12.co.uk
ns-586.awsdns-09.net
ns-73.awsdns-09.com
SOA:Serial: 1, TTL: 86400s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:107ms

Network Security

Port scanning and network exposure analysis.

Network Security

Port scanning and network exposure analysis

100/100
Score

Good Network Security Posture

LOW

No unnecessary services detected on common risky ports

How does keytruda.com compare?

See how keytruda.com stacks up against similar websites in the same industry.

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

The site is built on a modern React and Next.js framework, enabling server-side rendering and improved performance. It integrates multimedia content via Brightcove and uses Google Tag Manager for analytics and marketing tags. The presence of jQuery indicates some legacy or third-party components. The site is mobile-optimized with responsive design and accessibility features such as skip links. SEO is supported by meta tags, canonical links, and structured data in JSON-LD format describing the drug and medical webpage. Performance is moderate, with multiple CSS and JS chunks loaded asynchronously. Hosting provider details are not explicit but likely enterprise-grade given Merck's scale. Technical risks are minimal, though continuous performance optimization and security patching are recommended.
Professional PDF & Marketing Data

Download the keytruda.com report as PDF

Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.

PDF Report & Export

PDF download, email delivery, unlock code

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

Plan Comparison

FeaturePDF ReportMarketing+
Full security analysis
Professional PDF export
Email delivery
Lifetime access + unlock code
Contact emails & phones
Marketing outreach data

Already purchased?

Order summary

Domainkeytruda.com
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

Scan your own website

Liked the keytruda.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.

Or browse our directory of >10,000 scanned websites.

⭐ Verified Community Reviews

What others say about keytruda.com

Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

out of 5

0 reviews published

Loading reviews…

How did we do?

Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

Analyze Another Website